Carboplatin/Etoposide/Paclitaxel in the Treatment of Patients with Extensive Small-Cell Lung Cancer
- 1 February 2001
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 2 (3) , 204-209
- https://doi.org/10.3816/clc.2001.n.004
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Twenty Years of Phase III Trials for Patients With Extensive-Stage Small-Cell Lung Cancer: Perceptible ProgressJournal of Clinical Oncology, 1999
- Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1995
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI Journal of the National Cancer Institute, 1990
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- Small-Cell Carcinoma of the Lung: Combined Chemotherapy and RadiationAnnals of Internal Medicine, 1978
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Cell kinetic studies in patients with small cell carcinoma of the lungCancer, 1974
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971
- Oat cell carcinoma of the lung:A review of 138 casesCancer, 1969